ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) | MicrobiomeTrials← Back to trialsNCT04561518
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
RecruitingOBSERVATIONAL
Trial Details
Start: 2020-11-23Est. Completion: 2033-12-31
Enrollment target: 1,500 participants Locations- Clinical Trial Site, La Jolla, California, United States
- Clinical Trial Site, Los Angeles, California, United States
- Clinical Trial Site, Jacksonville, Florida, United States
- Clinical Trial Site, Iowa City, Iowa, United States
- Clinical Trial Site, Kansas City, Kansas, United States
- Clinical Trial Site, Baltimore, Maryland, United States
- Clinical Trial Site, Boston, Massachusetts, United States
- Clinical Trial Site, New York, New York, United States
- Clinical Trial Site, Durham, North Carolina, United States
- Clinical Trial Site, Columbus, Ohio, United States
- Clinical Trial Site, Philadelphia, Pennsylvania, United States
- Clinical Trial Site, Austin, Texas, United States
- Clinical Trial Site, Houston, Texas, United States
- Clinical Trial Site, Salvador, Brazil
- Clinical Trial Site, São Paulo, Brazil
- Clinical Trial Site, Sofia, Bulgaria
- Clinical Trial Site, Aarhus, Denmark
- Clinical Trial Site, Copenhagen, Denmark
Other microbiome trials you might be interested in
Hereditary Transthyretin-Mediated Amyloidosis With PolyneuropathyhATTR-PN
The purpose of this study is to:
* Determine the efficacy of nucresiran in patients with hATTR-PN by evaluating the eff…
Aurora, United StatesEst. completion Dec 27, 2027
Transthyretin Amyloidosis With Cardiomyopathy
The purpose of this study is to:
* Evaluate the efficacy of nucresiran compared to placebo on reducing all-cause mortal…
La Jolla, United StatesEst. completion May 28, 2030
Clinical Trial Site, Bordeaux, FranceClinical Trial Site, Bron, FranceClinical Trial Site, Créteil, FranceClinical Trial Site, Le Kremlin-Bicêtre, FranceClinical Trial Site, Marseille, FranceClinical Trial Site, Berlin, GermanyClinical Trial Site, Giessen, GermanyClinical Trial Site, Hanover, GermanyClinical Trial Site, Jerusalem, IsraelClinical Trial Site, Ramat Gan, IsraelClinical Trial Site, Milan, ItalyClinical Trial Site, Naples, ItalyClinical Trial Site, Palermo, ItalyClinical Trial Site, Roma, ItalyClinical Trial Site, Groningen, NetherlandsClinical Trial Site, Lisbon, PortugalClinical Trial Site, Porto, PortugalClinical Trial Site, Barcelona, SpainClinical Trial Site, Madrid, SpainClinical Trial Site, Palma, SpainClinical Trial Site, New Taipei City, TaiwanClinical Trial Site, Taipei, TaiwanTransthyretin Amyloid Cardiomyopathy (ATTR-CM)
The purpose of this randomised, double-blind, placebo-controlled, multicenter study is to evaluate the efficacy and safe…
La Jolla, United StatesEst. completion Feb 23, 2029